CVS Health (NYSE:CVS) Stock Rating Upgraded by Wall Street Zen

CVS Health (NYSE:CVS) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Sunday, Wall Street Zen reports.

A number of other analysts have also recently commented on CVS. Royal Bank Of Canada upped their price target on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Morgan Stanley lifted their price objective on CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Truist Financial increased their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Friday, September 11th. Finally, Wells Fargo & Company lifted their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Twenty-two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $107.24.

CVS Health Stock Down 1.5%

CVS opened at $87.54 on Friday. The firm’s 50 day simple moving average is $98.42 and its two-hundred day simple moving average is $91.42. The company has a market capitalization of $111.96 billion, a PE ratio of 23.16, a PEG ratio of 0.87 and a beta of 0.59. CVS Health has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the previous year, the firm posted $1.81 EPS. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts forecast that CVS Health will post 8.02 EPS for the current year.

Hedge Funds Weigh In On CVS Health

Several institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of CVS Health in the second quarter valued at $12,747,462,000. State Street Corp lifted its position in CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Wellington Management Group LLP lifted its position in CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Capital International Investors grew its stake in shares of CVS Health by 3.4% in the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock worth $2,189,793,000 after buying an additional 900,153 shares in the last quarter. Finally, Bank of America Corp DE increased its holdings in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.